<?xml version="1.0" encoding="iso-8859-1"?>
<?xml-stylesheet type="text/xsl" href="atom.xsl"?>
<feed xmlns="http://www.w3.org/2005/Atom">
       <title>Pharmaceuticals - livepress.com</title>
      <link>http://pharmaceuticals.livepress.com</link>
			<id>http://pharmaceuticals.livepress.com</id>
  <updated>2006-08-09 10:55:56</updated>
  <entry>
    <title><![CDATA[Hospira net falls as expenses jump 
    (Reuters)
]]></title>
    <link href="http://livepress.com/go/?136205"/>
    <id>http://livepress.com/go/?136205</id>
    <updated>2006-08-09 10:54:31</updated>
    <summary><![CDATA[Reuters - Hospira Inc. , which makes 
specialty  pharmaceuticals  and medication-delivery systems, on 
Wednesday said quarterly earnings fell 25 percent as sales were 
nearly flat and expenses surged.]]></summary>
  </entry>
  <entry>
    <title><![CDATA[Barr to refile contraceptive bid within 2 weeks 
    (Reuters)
]]></title>
    <link href="http://livepress.com/go/?135544"/>
    <id>http://livepress.com/go/?135544</id>
    <updated>2006-08-08 14:13:20</updated>
    <summary><![CDATA[    Reuters - Barr  Pharmaceuticals  Inc.  
aims to resubmit its application to sell its Plan B 
morning-after contraceptive pill within two weeks, the company 
said on Tuesday, following a meeting with U.S. Food and Drug 
Administration officials.  ]]></summary>
  </entry>
  <entry>
    <title><![CDATA[FDA, Barr to discuss looser Plan B sales 
    (Reuters)
]]></title>
    <link href="http://livepress.com/go/?130359"/>
    <id>http://livepress.com/go/?130359</id>
    <updated>2006-07-31 12:19:13</updated>
    <summary><![CDATA[Reuters - The U.S. Food and Drug 
Administration and Barr  Pharmaceuticals  Inc.  will meet 
to discuss the possible approval of nonprescription sales of 
the Plan B "morning-after" contraceptive to women 18 and older, 
the agency said on Monday.]]></summary>
  </entry>
  <entry>
    <title><![CDATA[FDA to talk with Barr on Plan B proposal 
    (Reuters)
]]></title>
    <link href="http://livepress.com/go/?130351"/>
    <id>http://livepress.com/go/?130351</id>
    <updated>2006-07-31 12:04:07</updated>
    <summary><![CDATA[Reuters - The U.S. Food and Drug 
Administration will meet with officials from Barr 
 Pharmaceuticals  Inc.  to discuss the possible approval 
of nonprescription sales of the Plan B "morning-after" 
contraceptive to women 18 and older, the agency said on Monday.]]></summary>
  </entry>
  <entry>
    <title><![CDATA[FDA clears AstraZeneca asthma drug 
    (Reuters)
]]></title>
    <link href="http://livepress.com/go/?124887"/>
    <id>http://livepress.com/go/?124887</id>
    <updated>2006-07-22 08:54:47</updated>
    <summary><![CDATA[    Reuters - AstraZeneca Plc  has won U.S. 
approval for its asthma drug Symbicort, significantly earlier 
than most industry analysts had expected, a person familiar 
with the matter said on Saturday.  ]]></summary>
  </entry>
  <entry>
    <title><![CDATA[Barr enters bidding race to buy Pliva: report 
    (Reuters)
]]></title>
    <link href="http://livepress.com/go/?97032"/>
    <id>http://livepress.com/go/?97032</id>
    <updated>2006-05-29 08:54:26</updated>
    <summary><![CDATA[Reuters - U.S. drug maker Barr  Pharmaceuticals  
 has entered the bidding for Croatian pharmaceutical 
group Pliva (PLVxq.L), the Financial Times newspaper said on 
Monday.]]></summary>
  </entry>
  <entry>
    <title><![CDATA[Barr says Lilly sues to stop generic weekly Prozac 
    (Reuters)
]]></title>
    <link href="http://livepress.com/go/?85269"/>
    <id>http://livepress.com/go/?85269</id>
    <updated>2006-05-11 11:23:04</updated>
    <summary><![CDATA[Reuters - Barr  Pharmaceuticals  Inc.  on 
Thursday said  Eli Lilly  & Co.  has sued the company, 
claiming Barr's generic weekly form of anti-depressant Prozac 
infringes the patent on Lilly's branded medicine.]]></summary>
  </entry>
  <entry>
    <title><![CDATA[Animal Rights Activists Target Glaxo Investors]]></title>
    <link href="http://livepress.com/go/?84676"/>
    <id>http://livepress.com/go/?84676</id>
    <updated>2006-05-10 16:56:35</updated>
    <summary><![CDATA[ Europe's biggest  pharmaceuticals  manufacturer, GlaxoSmithKline, says shareholders were told they would have their details posted on the internet if they did not sell their shares within 14 days in a threatening letter by animal rights...]]></summary>
  </entry>
  <entry>
    <title><![CDATA[Ariad's Shares Climb 40 Percent After It Wins Patent Case]]></title>
    <link href="http://livepress.com/go/?82436"/>
    <id>http://livepress.com/go/?82436</id>
    <updated>2006-05-05 03:04:29</updated>
    <summary><![CDATA[ Ariad  Pharmaceuticals  Inc. shares climbed up to 40 percent on Thursday after the company announced it won a patent infringement case against  Eli Lilly  and Co.
 Reuters reports a federal court in Massachusetts decided that Lilly's osteoporosis...]]></summary>
  </entry>
  <entry>
    <title><![CDATA[Texas plaintiffs seek over $1 bln in Vioxx case 
    (Reuters)
]]></title>
    <link href="http://livepress.com/go/?72353"/>
    <id>http://livepress.com/go/?72353</id>
    <updated>2006-04-20 14:09:20</updated>
    <summary><![CDATA[    Reuters - Attorneys suing  Merck  &amp; 
Co. Inc.  for the death of a 71-year-old man who took 
Vioxx asked a Texas jury on Thursday to award more than &#36;1 
billion in damages, but  Merck  lawyers said the  pharmaceuticals  
company should not have to pay anything.  ]]></summary>
  </entry>
  <entry>
    <title><![CDATA[DrugMax announces preliminary Q1 results 
    (Reuters)
]]></title>
    <link href="http://livepress.com/go/?65643"/>
    <id>http://livepress.com/go/?65643</id>
    <updated>2006-04-10 09:02:17</updated>
    <summary><![CDATA[Reuters -  Pharmaceuticals  distributor DrugMax Inc. 
 reported preliminary results for the first quarter on 
Monday.]]></summary>
  </entry>
  <entry>
    <title><![CDATA[FDA halts Cortex's sleep drug trial, shares plunge 
    (Reuters)
]]></title>
    <link href="http://livepress.com/go/?60964"/>
    <id>http://livepress.com/go/?60964</id>
    <updated>2006-04-03 10:33:32</updated>
    <summary><![CDATA[Reuters - Cortex  Pharmaceuticals  Inc.  shares lost 
almost half of their value in morning trade Monday after the 
U.S. Food and Drug Administration placed the clinical trial of 
the company's sleep disorder drug on hold.]]></summary>
  </entry>
  <entry>
    <title><![CDATA[SGX forges leukemia cancer deal with Novartis 
    (Reuters)
]]></title>
    <link href="http://livepress.com/go/?56849"/>
    <id>http://livepress.com/go/?56849</id>
    <updated>2006-03-28 03:24:55</updated>
    <summary><![CDATA[Reuters - SGX  Pharmaceuticals  Inc.  late 
on Monday said Swiss drugmaker Novartis AG  had 
licensed its experimental drugs to treat leukemia and could 
eventually pay it more than $515 million under the deal.]]></summary>
  </entry>
  <entry>
    <title><![CDATA[King may need new trial for Altace for kids 
    (Reuters)
]]></title>
    <link href="http://livepress.com/go/?55021"/>
    <id>http://livepress.com/go/?55021</id>
    <updated>2006-03-24 06:57:42</updated>
    <summary><![CDATA[Reuters - King  Pharmaceuticals , Inc.  on 
Friday said U.S. regulators have determined that clinical data 
on use by children of its Altace hypertension drug was 
insufficient and a new trial may be needed.]]></summary>
  </entry>
  <entry>
    <title><![CDATA[Shire sues Teva over generic Adderall XR plans 
    (Reuters)
]]></title>
    <link href="http://livepress.com/go/?41185"/>
    <id>http://livepress.com/go/?41185</id>
    <updated>2006-03-03 07:26:28</updated>
    <summary><![CDATA[Reuters - British drugmaker Shire Plc  said 
on Friday it was suing Teva  Pharmaceuticals   over the 
Israeli drugmaker's plans to make a cheap, copycat version of 
hyperactivity drug Adderall XR.]]></summary>
  </entry>
  <entry>
    <title><![CDATA[King Pharma posts quarterly net loss 
    (Reuters)
]]></title>
    <link href="http://livepress.com/go/?38894"/>
    <id>http://livepress.com/go/?38894</id>
    <updated>2006-02-28 07:45:13</updated>
    <summary><![CDATA[Reuters - Drugmaker King  Pharmaceuticals  Inc. 
 on Tuesday posted a quarterly loss after taking a large 
charge tied to a research deal.]]></summary>
  </entry>
</feed>